scPharmaceuticals Inc. (SCPH)

scPharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	40.81	75.66	46.81	71.06	74.27	71.82
Short-Term Investments	0.28	1.02	30.36	48.55	1.03	33.28
Cash & Short-Term Investments	41.09	76.68	77.17	119.61	75.3	105.1
Cash Growth	5.70%	-0.64%	-35.48%	58.85%	-28.35%	44.71%
Accounts Receivable	19.41	11.72	4.49	-	-	-
Receivables	19.41	11.72	4.49	-	-	-
Inventory	14.57	13.9	8.84	1.23	-	-
Prepaid Expenses	3.65	3.55	2.44	2.28	2.79	2.61
Restricted Cash	-	-	-	0.18	0.18	-
Other Current Assets	-	-	-	-	-	0.12
Total Current Assets	78.73	105.85	92.94	123.31	78.28	107.83
Property, Plant & Equipment	1.22	1.33	1.46	0.62	0.48	0.91
Other Long-Term Assets	0.3	0.34	0.08	0.27	0.28	0.31
Total Assets	80.26	107.52	94.48	124.2	79.04	109.05

Liabilities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Accounts Payable	4.03	3.88	4	1.52	0.54	1.67
Accrued Expenses	14.8	9.73	8.75	5.29	3.99	4.75
Current Portion of Long-Term Debt	-	-	-	-	9.81	2.41
Current Portion of Leases	0.26	0.24	0.18	0.57	0.48	0.46
Current Income Taxes Payable	-	-	-	-	0.01	0.04
Other Current Liabilities	1.34	1.02	0.21	0.04	0.03	-
Total Current Liabilities	20.43	14.88	13.13	7.42	14.85	9.32
Long-Term Debt	51.2	51.35	38.81	36.79	7.35	16.86
Long-Term Leases	0.98	1.1	1.28	0.01	-	0.48
Other Long-Term Liabilities	28.96	26.87	4.03	7.55	0.37	0.22
Total Liabilities	101.57	94.2	57.26	51.76	22.57	26.88

Shareholders' Equity

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Common Stock	0.01	0.01	0	0	0	0
Additional Paid-In Capital	382.94	379.81	318.56	298.93	246.17	243.83
Retained Earnings	-404.26	-366.49	-281.35	-226.54	-189.7	-161.66
Comprehensive Income & Other	-	-	-0	0.03	-0	0
Total Common Equity	-21.32	13.32	37.22	72.43	56.47	82.17
Shareholders' Equity	-21.32	13.32	37.22	72.43	56.47	82.17
Total Liabilities & Equity	80.26	107.52	94.48	124.2	79.04	109.05

Additional Metrics

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Debt	52.45	52.69	40.27	37.37	17.64	20.21
Net Cash (Debt)	-11.36	23.98	36.9	82.25	57.67	84.89
Net Cash Growth	-	-35.01%	-55.13%	42.62%	-32.07%	64.53%
Net Cash Per Share	-0.22	0.54	0.96	2.90	2.11	3.46
Filing Date Shares Outstanding	53.3	50.28	36.05	35.77	27.37	27.36
Total Common Shares Outstanding	53.29	50.1	35.97	34.26	27.37	27.33
Working Capital	58.3	90.97	79.8	115.89	63.43	98.51
Book Value Per Share	-0.40	0.27	1.03	2.11	2.06	3.01
Tangible Book Value	-21.32	13.32	37.22	72.43	56.47	82.17
Tangible Book Value Per Share	-0.40	0.27	1.03	2.11	2.06	3.01
Machinery	0.13	0.13	0.11	0.15	0.14	0.13
Leasehold Improvements	0.01	0.01	0.01	0.1	0.1	0.1

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jan 1, 2000

Data Sources Report a data error